China’s most high-profile InsurTech is struggling on the public markets.
Hong Kong-listed ZhongAn’s share price has fallen by almost two-thirds over the last 12 months.
China’s most high-profile InsurTech is struggling on the public markets.
Hong Kong-listed ZhongAn’s share price has fallen by almost two-thirds over the last 12 months.